Sigve Andersen
Job description
Mitt forskningsområde er hovedsaklig translasjonell kreftforskning på lungekreft. Jeg er også involvert i forskning innen andre tumorgrupper som prostata, kolorektalkreft og innen fagfeltet palliasjon. Min undervisning er hovedsaklig orientert rundt palliasjon, men også generell kreft. Jeg er også fast medlem i eksamenskommisjonen for avsluttende eksamen.
Falah Jabar Rahim,
Lill-Tove Rasmussen Busund,
Biagio Ricciuti,
Masoud Tafavvoghi,
Thomas Karsten Kilvær,
David J. Pinato
et al.:
Fully Automatic Content-Aware Tiling Pipeline for Pathology Whole Slide Images
Dagny Førde,
Thomas Karsten Kilvær,
Mona Irene Pedersen,
Ana Paola Lombardi,
Irene D’arsiè,
Erna-Elise Paulsen
et al.:
Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status
Marianne Jensen Hjermstad,
Aleksandra Pirnat,
Nina Kathrine Aass,
Sigve Andersen,
Guro Lindviksmoen Astrup,
Olav Dajani
et al.:
PALLiative care in ONcology (PALLiON): A cluster-randomised trial investigating the effect of palliative care on the use of anticancer treatment at the end of life
Dagny Førde,
Thomas Karsten Kilvær,
Mona Irene Pedersen,
Egil Støre Blix,
Ilona Halva Urbarova,
Erna-Elise Paulsen
et al.:
High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC
Marie Grøn Sælen,
Line Veronika Hjelle,
Erling Johan Aarsæther,
Tore Knutsen,
Sigve Andersen,
Anne Gry Bentzen
et al.:
Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy
Hallgeir Selven,
Lill-Tove Rasmussen Busund,
Sigve Andersen,
Mona Irene Pedersen,
Ana Paola Lombardi,
Thomas Karsten Kilvær
:
High Expression of IRS-1, RUNX3 and SMAD4 Are Positive Prognostic Factors in Stage I–III Colon Cancer
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Ana Paola Lombardi,
Mette Pøhl
et al.:
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
Mehrdad Rakaee,
Sigve Andersen,
K. Giannikou,
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Lill-Tove Rasmussen Busund
et al.:
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
Line Veronika Hjelle,
Marie Grøn Sælen,
Erling Johan Aarsæther,
Tore Knutsen,
Sigve Andersen,
Anne Gry Bentzen
et al.:
The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy
Hallgeir Selven,
Sigve Andersen,
Mona Irene Pedersen,
Ana Paola Lombardi,
Lill-Tove Rasmussen Busund,
Thomas Karsten Kilvær
:
High expression of miR-17-5p and miR-20a-5p predicts favorable disease-specific survival in stage I-III colon cancer
Therese Haugdahl Nøst,
Anne Heidi Skogholt,
Ilona Halva Urbarova,
Robin Mjelle,
Erna-Elise Paulsen,
Tom Dønnem
et al.:
Increased levels of microRNA-320 in blood serum and plasma is associated with imminent and advanced lung cancer
Mehrdad Rakaee,
Elio Adib,
Biagio Ricciuti,
Lynette M. Sholl Sholl,
Weiwei Shi,
Joao V. Alessi
et al.:
Association of machine learning-based assessment of tumor-infiltrating lymphocytes on standard histologic images with outcomes of immunotherapy in patients with NSCLC
Hallgeir Selven,
Lill-Tove Rasmussen Busund,
Sigve Andersen,
Roy M. Bremnes,
Thomas Karsten Kilvær
:
High expression of microRNA‑126 relates to favorable prognosis for colon cancer patients
Sissel Gyrid Freim Wahl,
Yan Dai Hong,
Elisabeth Fritzke Emdal,
Thomas Berg,
Tarje Onsøien Halvorsen,
Anine Larsen Ottestad
et al.:
The prognostic effect of KRAS mutations in non-small cell lung carcinoma revisited: A norwegian multicentre study
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona I. Pedersen,
Lise Martine Ingebriktsen,
Tom Dønnem
et al.:
Overexpression of mir-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer—a multi-institutional study
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Lise Martine Ingebriktsen,
Roy M. Bremnes
et al.:
High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
Håkon Andre Ramberg,
Elin Richardsen,
Gustavo Antonio De Souza,
Mehrdad Rakaee,
Maria Stensland,
Peder Rustøen Braadland
et al.:
Proteomic analyses identify major vault protein as a prognostic biomarker for fatal prostate cancer
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Simin Jamaly,
Thomas Berg,
Erna-Elise Paulsen,
Marte Berglund
et al.:
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Roy M. Bremnes,
Lill-Tove Rasmussen Busund
et al.:
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
Bente Ervik,
Sigve Andersen,
Helge Skirbekk,
Tom Dønnem
:
Evaluating a centralised cancer support centre in the remote region of Northern Norway
Elin Richardsen,
Sigve Andersen,
Christian Melbø-Jørgensen,
Mehrdad Rakaee,
Nora Ness,
Samer Al-Saad
et al.:
MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer
Mehrdad Rakaee,
Lill-Tove Busund,
Simin Jamaly,
Erna-Elise Paulsen,
Elin Richardsen,
Sigve Andersen
et al.:
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
Elin Richardsen,
Sigve Andersen,
Samer Al-Saad,
Mehrdad Rakaee,
Yngve Nordby,
Mona Irene Pedersen
et al.:
Low expression of miR-424-3p is highly correlated with clinical failure in prostate cancer
Kaja Konstanse Skjefstad,
Charles Johannessen,
Thea K.W. Grindstad,
Thomas Karsten Kilvær,
Erna Elise Paulsen,
Mona Irene Pedersen
et al.:
A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
Masoud Tafavvoghi,
Erna-Elise Paulsen,
Falah Jabar Rahim,
Sigve Andersen,
Ana Paola Lombardi,
Elin Richardsen
et al.:
51P Deep learning-based detection of non-angiogenic growth patterns in early-stage lung cancer
Per Niklas Benzler Waaler,
Magdalena Solveig Robertsen,
Erna-Elise Paulsen,
Sigve Andersen,
Elin Richardsen,
Åslaug Helland
et al.:
21P Integration of genomic and clinical data for relapse prediction in early-stage non-small cell lung cancer
Masoud Tafavvoghi,
Falah Jabar Rahim,
Sigve Andersen,
Erna-Elise Paulsen,
A. Cortellini,
P. Lombardi
et al.:
219P Benchmarking state-of-the-art deep learning models for tumor-infiltrating lymphocytes (TILs) quantification
Mehrdad Rakaee,
Per Niklas Benzler Waaler,
Falah Jabar Rahim,
Krinio Giannikou,
Elio Adib,
Sigve Andersen
et al.:
Abstract 5366: DRAGEN pipeline validation for somatic variant detection in diagnostics using TSO500 panel
M.S. Robertsen,
Per Niklas Benzler Waaler,
Sigve Andersen,
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Sissel Gyrid Freim Wahl
et al.:
1802P Tissue tumor mutational burden and risk of recurrence in early-stage non-small cell lung cancer
Mehrdad Rakaee,
Masoud Tafavvoghi,
A. Cortellini,
Sigve Andersen,
Falah Jabar Rahim,
L. Brunetti
et al.:
P1.11.62 Deep Learning Histopathology Model for PD-L1 (TPS) and Immunotherapy Outcome Prediction in Non-Small Cell Lung Cancer
Stein Kaasa,
Dagny Renata Faksvåg Haugen,
Sigve Andersen,
Nina Kathrine Aass,
Anne Tove Brenne,
Eva-Kristin Norum Gravdahl
et al.:
Regjeringen gir dødshjelp til palliativ medisin
2024 ARKIV
Falah Jabar Rahim,
Sigve Andersen,
Erna-Elise Paulsen,
Masoud Tafavvoghi,
Elin Helmine Richardsen,
Sissel Gyrid Freim Wahl
et al.:
Integrating Artificial intelligence (AI)-based lymphocytic infiltration assessment in early-stage NSCLC: A sub-study of the TNM-I trial
Øyvind Rolland,
Sigve Andersen,
Stian Aagnes,
Åslaug Helland
:
Stian har livstruende lungekreft: – Jeg er beviset på at forskning nytter
08. Juni 2023 ARKIV
Marianne Jensen Hjermstad,
Aleksandra Pirnat,
Nina Kathrine Aass,
Sigve Andersen,
Guro Lindviksmoen Astrup,
Olav Dajani
et al.:
1592MO Anticancer therapy at the end-of-life: A cluster-randomized trial
Tonje Lundeby,
Nina Kathrine Aass,
Sigve Andersen,
Sjur Bjørnar Hanssen,
Marianne Jensen Hjermstad,
Stein Kaasa
et al.:
Family carers' experiences with brain metastases: A longitudinal study
2023 ARKIV
Mehrdad Rakaee,
Elio Adib,
Biagio Ricciuti,
Lynette M. Sholl,
Weiwei Shi,
Joao V Alessi
et al.:
Computational pathology by Artificial Intelligence (AI) on quantifying the lymphocytic infiltration predicts the immunotherapy response in NSCLC
2022 ARKIV
Mehrdad Rakaee,
Elio Adib,
Biagio Ricciuti,
Lynette M. Sholl,
Joao V.Alessi,
Alessio Cortellini
et al.:
Digital quantification of lymphocytic infiltration on routine H&E images and immunotherapy response in non-small cell lung cancer
2022 ARKIV
Mehrdad Rakaee,
Elio Adib,
Biagio Ricciuti,
Lynette M. Sholl,
Weiwei Shi,
Joao V.Alessi
et al.:
Artificial intelligence in digital pathology approach identifies the predictive impact of tertiary lymphoid structures with immune-checkpoints therapy in NSCLC
Ilona H. Urbarova,
Therese Haugdahl Nøst,
Anne Heidi Skogholt,
Robin Mjelle,
Erna-Elise Paulsen,
Tom Dønnem
et al.:
Increased Levels of mRNAs and miRNAs Associated with Imminent and Advanced Lung Cancer
Therese Haugdahl Nøst,
Ilona Halva Urbarova,
Anne Heidi Skogholt,
Robin Mjelle,
Erna Elise Paulsen,
Tom Dønnem
et al.:
Increased levels of mRNAs and miRNAs associated with imminent and advanced lung cancer
2022 ARKIV
Stein Kaasa,
Marianne Bahus,
Sigve Andersen,
Peder Broen,
Helge Farsund,
Anne Marie Flovik
et al.:
De er døende. Gi dem lindring
2020 ARKIV
Marianne Bahus,
Sigve Andersen,
Peder Broen,
Helge Farsund,
Anne Marie Flovik,
Søren Vincent Hagerup
et al.:
Organisering av det palliative tilbudet
Faglig begrunnet eller et udemokratisk politisk spill?
24. August 2020 ARKIV
Marianne Jensen Hjermstad,
Nina Kathrine Aass,
Sigve Andersen,
Cinzia Brunelli,
Olav Dajani,
Herish Ahmed
et al.:
PALLiON - PALLiative care Integrated in ONcology: Study protocol for a Norwegian national cluster-randomized control trial with a complex intervention of early integration of palliative care
Sigve Andersen,
Tom Dønnem
:
Krafttak mot kreft
14. März 2019 ARKIV
Tom Dønnem,
Sigve Andersen
:
Jakter på kroppens krigerceller
18. September 2019 ARKIV
Tom Dønnem,
Sigve Andersen
:
Jakter på kroppens krigerceller
05. September 2019 ARKIV
Sigve Andersen
:
Folkemøte om prostatakreft
2019 ARKIV
Kristin Benjaminsen Borch,
Sigve Andersen,
Line Merethe Oldervoll,
Sveinung Berntsen
:
Hva vet onkologer om fysisk aktivitet og kreft?
2019 ARKIV
Jan Henrik Rosland,
Olav Hevrøy,
Birthe Lie Hauge,
Anne Kari Knudsen,
Peder Broen,
Sigve Andersen
:
Nasjonalt handlingsprogram for palliasjon i kreftomsorgen
Helsedirektoratet 2019 ARKIV
Bente Ervik,
Tone Nordøy,
Sigve Andersen
:
Fruktene av "Lindring i nord"
The 50 latest publications is shown on this page. See all publications in Cristin here →
Research interests
Translasjonell kreftforskning innen lunge og prostatakreft
Lindrende behandling